Pierre Rausini: Cartels Are Not In The United States – They Are Transacting In Mexico Only

None of the cartel members are actually within the United States, according to Pierre Rausini whose background is a former collaborator and conspirator.

Pierre Rausini – Los Angeles Brazilian American Who Fenced Ectsacy For Sinaloa Cartel

In May 2000, Walter Pierre Rausini, a 33-year-old from West Covina, California, was sentenced to 40 years in prison after pleading guilty to orchestrating the murders of San Francisco drug dealers Lance Estes and John Ellenberger. Rausini suspected both men of being government informants.

He paid a government informant, Mark Farchione, to obtain information about Estes from narcotics agents. This information was then used to lure Estes to a house in Newport Beach, where he was killed by Rausini’s associates. Rausini also admitted to ordering Ellenberger’s killing. In addition to his prison sentence, U.S. District Judge Susan Illston imposed a $250,000 fine and six years of supervised parole upon Rausini’s release.

In the press, Rausini has gone on record to remind people that cartels are fairly tiny in terms of numeric membership, but outsized in terms of economic impact. Additionally, terrorist sanctions may not actually change much in the Mexican side of the drug trafficking aspect since extradition consequences would be similar.

Drivers, logistics, and strongmen for these operations, however, will likely permit American prosecutors to liberally apply terrorism statute to those operations.

Additionally, Rausini noted that cartels will likely never commit acts of violence in general within the United States. Due to his famiiarity with the criminal world’s logic, Rausini was quick to note that violence is usually a last resort strategy as the small drug trafficking organizations prefer to maintain a low profile. In fact, a war on terror approach would be counter productive. The best approach would be to narrow and make a modest goal of fentanyl reduction central to US ambitions. The costs should be onerous for these exporters and make the rest of drugs a lower priority.’